IVD 원료 시장 보고서(2025년)
IVD Raw Materials Global Market Report 2025
상품코드 : 1760584
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,510,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,409,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,309,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

IVD 원료 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 10.1%로 407억 4,000만 달러에 달할 것으로 예상됩니다. 예측기간 동안 예상되는 성장의 원동력은 고감도 및 신속한 진단 솔루션에 대한 수요 증가, 암 영역에서의 분자진단 이용 확대, 노인 인구 증가와 이에 따른 질병 부담 증가, 동반자 진단에 대한 요구 증가, 바이오제약기업 투자 확대 등입니다. 예측 기간 동안 예상되는 주요 동향으로는 재조합 원료와 합성 원료로의 이동, 특수 원료를 필요로 하는 멀티플렉스 분석의 통합, 동결건조 시약과 즉시 사용할 수 있는 시약 포맷의 채택, 마이크로유체 시스템이나 랩 칩 시스템용으로 설계된 원료의 개발 등을 들 수 있습니다.

감염의 유행 증가는 IVD 원료 시장의 성장을 이끌 것으로 예측됩니다. 감염은 유해한 미생물에 의해 야기되며 개체들과 생물간에 퍼질 수 있습니다. 이러한 질병의 만연이 확대되고 있는 것은 급속한 도시화에 의한 것이 크고, 인구밀도를 높이고, 위생 및 의료 인프라에 부담을 가하는 것으로 감염증의 만연을 조장하고 있습니다. IVD 원료는 조기 발견과 효과적인 질병 관리를 위한 정확한 진단 검사를 가능하게 함으로써 감염성 질환 대책에 중요한 역할을 하고 있습니다. 예를 들어, 2023년 5월에 덴마크에 본사를 둔 의학연구소 Statens Serum Institut가 발표한 보고서에 따르면, 2021년에는 C형 만성 간염 환자가 146명이었고, 그 중 72%(105명)가 남성이었습니다. 이런 식으로 감염의 유행이 확대되고 있다는 것은 IVD 원료 시장의 확대에 기여하고 있습니다.

IVD 원료 시장의 각 기업은 지역의 진단 능력을 강화하고 의료의 자급 자족을 촉진하기 위해 체외 진단용 의약품 제조 시설 등의 선진 솔루션의 개발에 점점 주력하고 있습니다. 제조 및 품질 및 컴플라이언스를 테스트하는 전문적인 장소입니다. 2024년 1월 나이지리아 기반의 헬스 테크 기업인 콜렉사 바이오센서 리미티드(Colexa Biosensor Limited)는 나이지리아 제약 제조업체인 코딕스 파마 리미티드(Codix Pharma Limited)와 협력하여 라고스에 사하라 이남 아프리카 최초의 체외 진단(IVD) 제조 시설을 설립했습니다. 당뇨병 유병률에 종사하고 진단에 대한 접근성을 개선하는 것을 목적으로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장의 거시경제 시나리오 : 금리, 인플레이션, 지정학, 무역 전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 : 경쟁 벤치마킹 대시보드

제33장 주요 기업 합병 및 인수(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가 부문과 전략

제36장 부록

SHW
영문 목차

영문목차

In vitro diagnostics (IVD) raw materials are the essential biological and chemical substances needed for the creation and development of diagnostic assays that analyze biological samples outside the human body. These materials help in the detection, measurement, or evaluation of analytes in clinical samples for diagnostic, screening, or monitoring purposes.

The primary products in IVD raw materials include antibodies, antigens, enzymes, proteins, biological buffers, and others. Antibodies in IVD raw materials are specialized proteins designed to detect and bind to specific antigens, facilitating the accurate identification of diseases or conditions in diagnostic tests. These materials are utilized in technologies such as molecular diagnostics, clinical chemistry, immunochemistry, and others, by end users including pharmaceutical and biotechnology companies, diagnostic laboratories, contract research organizations, and others.

The IVD raw materials market research report is one of a series of new reports from The Business Research Company that provides IVD raw materials market statistics, including IVD raw materials industry global market size, regional shares, competitors with a IVD raw materials market share, detailed IVD raw materials market segments, market trends and opportunities, and any further data you may need to thrive in the IVD raw materials industry. This IVD raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The IVD raw materials market size has grown rapidly in recent years. It will grow from $25.13 billion in 2024 to $27.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period can be attributed to the increasing prevalence of infectious and chronic diseases, a rising demand for laboratory-based diagnostic testing, a greater use of enzyme- and protein-based reagents in diagnostics, the expansion of clinical diagnostic laboratories, and heightened awareness and efforts for early disease detection.

The IVD raw materials market size is expected to see rapid growth in the next few years. It will grow to $40.74 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated in the forecast period is driven by the growing demand for high-sensitivity and rapid diagnostic solutions, the expanding use of molecular diagnostics in oncology, the rising geriatric population and its associated disease burden, the increasing need for companion diagnostics, and growing investments from biopharmaceutical companies. Key trends expected in the forecast period include a shift towards recombinant and synthetic raw materials, the integration of multiplex assays that require specialized materials, the adoption of lyophilized and ready-to-use reagent formats, and the development of raw materials designed for microfluidic and lab-on-a-chip systems.

The increasing prevalence of infectious diseases is expected to drive the growth of the IVD raw materials market. Infectious diseases are caused by harmful microorganisms that can spread between individuals or organisms. The growing prevalence of these diseases is largely due to rapid urbanization, which fosters the spread of infections by increasing population density and putting a strain on sanitation and healthcare infrastructure. IVD raw materials play a vital role in addressing infectious diseases by enabling the creation of accurate diagnostic tests for early detection and effective disease management. For example, a report published in May 2023 by the Statens Serum Institut, a medical laboratory based in Denmark, stated that in 2021, there were 146 cases of chronic hepatitis C, with 72% (105 cases) affecting men, and this number rose to 196 cases in 2022, with 67% (131 cases) involving men. Thus, the growing prevalence of infectious diseases is contributing to the expansion of the IVD raw materials market.

Companies in the IVD raw materials market are increasingly focusing on developing advanced solutions, such as IVD manufacturing facilities, to enhance regional diagnostic capabilities and promote healthcare self-sufficiency. An IVD manufacturing facility is a specialized place where diagnostic devices and equipment are designed, produced, and tested for quality and compliance. For instance, in January 2024, Colexa Biosensor Limited, a Nigeria-based health technology company, collaborated with Codix Pharma Limited, a Nigerian pharmaceutical manufacturer, to launch Sub-Saharan Africa's first IVD manufacturing facility in Lagos. This facility, which produces the onpoint blood glucose meter and strips, represents a significant step forward for Africa's healthcare sector, aimed at tackling the rising diabetes prevalence and improving access to diagnostics. The facility can produce 3.6 million packs annually, with plans to expand production to 10.8 million packs, focusing initially on West Africa's needs.

In November 2022, Fapon Biotech Inc., a China-based life sciences company offering high-quality IVD raw materials, partnered with Roche Diagnostics to drive innovation and growth within China's in vitro diagnostics industry. Through this collaboration, both companies aim to leverage their combined resources to develop and improve comprehensive solutions tailored to local needs, speed up research and development, and foster continuous innovation in the Chinese IVD industry. Roche Diagnostics, a Swiss pharmaceutical company, specializes in diagnostic tests, instruments, and digital solutions.

Major players in the ivd raw materials market are F. Hoffmann-La Roche, Merck KGaA, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company (BD), Agilent Technologies, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., and NOVA Biologics Inc.

North America was the largest region in the IVD raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in IVD raw materials report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the IVD raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The IVD raw materials market consists of sales of protein stabilizers, phosphate-buffered saline, washing buffers, and chelating agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

IVD Raw Materials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ivd raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for ivd raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ivd raw materials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. IVD Raw Materials Market Characteristics

3. IVD Raw Materials Market Trends And Strategies

4. IVD Raw Materials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global IVD Raw Materials Growth Analysis And Strategic Analysis Framework

6. IVD Raw Materials Market Segmentation

7. IVD Raw Materials Market Regional And Country Analysis

8. Asia-Pacific IVD Raw Materials Market

9. China IVD Raw Materials Market

10. India IVD Raw Materials Market

11. Japan IVD Raw Materials Market

12. Australia IVD Raw Materials Market

13. Indonesia IVD Raw Materials Market

14. South Korea IVD Raw Materials Market

15. Western Europe IVD Raw Materials Market

16. UK IVD Raw Materials Market

17. Germany IVD Raw Materials Market

18. France IVD Raw Materials Market

19. Italy IVD Raw Materials Market

20. Spain IVD Raw Materials Market

21. Eastern Europe IVD Raw Materials Market

22. Russia IVD Raw Materials Market

23. North America IVD Raw Materials Market

24. USA IVD Raw Materials Market

25. Canada IVD Raw Materials Market

26. South America IVD Raw Materials Market

27. Brazil IVD Raw Materials Market

28. Middle East IVD Raw Materials Market

29. Africa IVD Raw Materials Market

30. IVD Raw Materials Market Competitive Landscape And Company Profiles

31. IVD Raw Materials Market Other Major And Innovative Companies

32. Global IVD Raw Materials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The IVD Raw Materials Market

34. Recent Developments In The IVD Raw Materials Market

35. IVD Raw Materials Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기